Co-expression and prognostic significance of the HER family members, EGFRvIII, c-MET, CD44 in patients with ovarian cancer

Схожие документы

• Co-expression and prognostic significance of putative CSC markers CD44, CD133, wild-type EGFR and EGFRvIII in metastatic colorectal cancer
  по: Khelwatty, Said Abdullah, et al.
  Опубликовано: (2019)
• HER2 Expression Is Predictive of Survival in Cetuximab Treated Patients with RAS Wild Type Metastatic Colorectal Cancer
  по: Khelwatty, Said A., et al.
  Опубликовано: (2021)
• Co-Expression of HER Family Members in Patients with Dukes’ C and D Colon Cancer and Their Impacts on Patient Prognosis and Survival
  по: Khelwatty, Said Abdullah, et al.
  Опубликовано: (2014)
• The impact of co-expression of wild-type EGFR and its ligands determined by immunohistochemistry for response to treatment with cetuximab in patients with metastatic colorectal cancer
  по: Khelwatty, Said, et al.
  Опубликовано: (2016)
• Impact of the putative cancer stem cell markers and growth factor receptor expression on the sensitivity of ovarian cancer cells to treatment with various forms of small molecule tyrosine kinase inhibitors and cytotoxic drugs
  по: Puvanenthiran, Soozana, et al.
  Опубликовано: (2016)